Complete Remission of Schnitzler Syndrome and Waldenström Macroglobulinemia under Rituximab-Cyclophosphamide-Dexamethasone

Publisher： Karger

E-ISSN： 1421-9832|230|1|18-22

ISSN： 1018-8665

Source： Dermatology, Vol.230, Iss.1, 2014-11, pp. : 18-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Schnitzler Syndrome – A Treatment at Last?

By  

Dermatology, Vol. 205, Iss. 1, 2002-07 ,pp. : 1-2

Karger

Access to resources Recommend Favorite

Successful Treatment of Schnitzler’s Syndrome with Interferon Alfa-2b

By  

Dermatology, Vol. 205, Iss. 1, 2002-07 ,pp. : 74-74

Karger

Access to resources Recommend Favorite

Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide

By  

Case Reports in Dermatology, Vol. 5, Iss. 1, 2013-04 ,pp. : 115-119

Karger

Access to resources Recommend Favorite

Long-Term Efficacy of Dexamethasone-Cyclophosphamide Pulse Therapy in Pemphigus

By  

Dermatology, Vol. 204, Iss. 3, 2002-05 ,pp. : 228-231

Karger

Access to resources Recommend Favorite

Report of a Case of Schnitzler’s Syndrome Treated Successfully with Interferon Alpha 2b

By  

Dermatology, Vol. 205, Iss. 1, 2002-07 ,pp. : 54-56

Karger

Access to resources Recommend Favorite